Document Detail


Retinoic acid-induced transition from protein kinase C beta to protein kinase C alpha in differentiated F9 cells: correlation with altered regulation of proto-oncogene expression by phorbol esters.
MedLine Citation:
PMID:  8732669     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Retinoic acid (RA) induced differentiation of F9 embryonal carcinoma cells is accompanied by changes in cellular responsiveness to extracellular signals. These changes include an increase in the AP1 transcription factor that is associated with the expression of differentiation markers (e.g., cytokeratin 18 and plasminogen activator). Since AP1 activity is a target for protein kinase C (PKC)-regulated changes in gene expression, we have examined the effects of RA on the expression and function of the PKC isozymes. F9 stem cells express PKC beta, delta, epsilon, and zeta. RA-induced differentiation to primitive endoderm led to a transition from PKC beta to PKC alpha expression. Additional treatment with dibutyryl cyclic AMP (dbcAMP), required for terminal differentiation into parietal endoderm, further increased PKC alpha expression and total PKC activity. RA and dbcAMP had negligible effects on the expression of PKC delta, epsilon, and zeta. The PKC beta to PKC alpha transition was specific for parietal endoderm; aggregation of RA-treated F9 cells induced visceral endoderm differentiation with elevated expression of PKC beta. The PKC activation with phorbol esters induced the expression of c-fos, c-jun, and junB proto-oncogenes in F9 stem cells. In the presence of either RA or RA and dbcAMP, phorbol ester treatment enhanced the expression of type IV collagen, a parietal endoderm marker. It also increased the expression of c-jun gene but not c-fos. The specific involvement of PKC beta in c-fos induction and PKC alpha in type IV collagen induction was confirmed in each PKC isozyme-transfected F9 cells. Together, our data demonstrate that the RA-induced (and dbcAMP-induced) changes in conventional PKC expression alters gene expression during parietal endoderm formation.
Authors:
F R Khuri; Y Cho; D A Talmage
Related Documents :
18284919 - Fad24, a regulator of adipogenesis and dna replication, inhibits h-ras-mediated transfo...
24295739 - Modulation of sodium-bicarbonate co-transporter (slc4a4/nbce1) protein and mrna express...
7547509 - Regulation of cathepsin d gene expression in hl-60 cells by retinoic acid and calcitriol.
2963209 - Immortalization by c-myc, h-ras, and ela oncogenes induces differential cellular gene e...
8336949 - Synergistic increase of phorbol ester-induced c-fos mrna expression by retinoic acid th...
11274229 - Suppression of constitutive but not il-1beta-inducible expression of monocyte chemoattr...
17722049 - The excitatory thalamo-"cortical" projection within the song control system of zebra fi...
15939469 - Interferon beta increases c-myc proteolysis in mouse monocyte/macrophage leukemia cells.
17052179 - The kaposi's sarcoma-associated herpesvirus orf57 protein: a pleurotropic regulator of ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research     Volume:  7     ISSN:  1044-9523     ISO Abbreviation:  Cell Growth Differ.     Publication Date:  1996 May 
Date Detail:
Created Date:  1996-10-31     Completed Date:  1996-10-31     Revised Date:  2012-06-25    
Medline Journal Info:
Nlm Unique ID:  9100024     Medline TA:  Cell Growth Differ     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  595-602     Citation Subset:  IM    
Affiliation:
Institute of Human Nutrition, Columbia University, New York, New York 10032, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Bucladesine / pharmacology
Cell Differentiation / physiology
Collagen / genetics
Embryonal Carcinoma Stem Cells
Endoderm / cytology,  physiology
Gene Expression Regulation, Developmental / drug effects,  physiology
Genes, fos / genetics*
Genetic Markers
Isoenzymes / metabolism*
Mice
Neoplastic Stem Cells / cytology,  drug effects,  enzymology
Phorbol Esters / pharmacology*
Protein Kinase C / metabolism*
Protein Kinase C-alpha
Time Factors
Transfection
Tretinoin / pharmacology
Tumor Cells, Cultured / cytology
Grant Support
ID/Acronym/Agency:
HD26854/HD/NICHD NIH HHS
Chemical
Reg. No./Substance:
0/Genetic Markers; 0/Isoenzymes; 0/Phorbol Esters; 302-79-4/Tretinoin; 362-74-3/Bucladesine; 9007-34-5/Collagen; EC 2.7.1.-/protein kinase C beta; EC 2.7.11.13/Prkca protein, mouse; EC 2.7.11.13/Protein Kinase C; EC 2.7.11.13/Protein Kinase C-alpha

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Protein kinase C beta 1 and protein kinase C beta 2 activate p57 mitogen-activated protein kinase an...
Next Document:  Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leuk...